Your browser doesn't support javascript.
loading
Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience
Indian J Ophthalmol ; 2022 Mar; 70(3): 1019-1024
Artigo | IMSEAR | ID: sea-224213
ABSTRACT

Purpose:

To assess the outcome and response of transcutaneous retrobulbar injection of amphotericin B (TRAMB) in post?coronavirus disease of 2019 (COVID?19) rhino?orbito?cerebral mucormycosis (ROCM) and to establish a scoring system in guiding treatment modalities.

Methods:

An interventional, prospective study was done on 82 eyes of post?COVID?19 ROCM from May 2021 to July 2021. A comprehensive multi?departmental evaluation along with detailed ophthalmic examination, laboratory investigations, and radiological examination was done. Scoring points were given to each symptom, sign, and radiological features of orbit and the total score was taken. Based on these scores, severity of disease was grouped into A, B, and C corresponding to mild, moderate, and severe orbital ROCM. One milliliter of reconstituted liposomal amphotericin B was given to all patients every alternate day as three doses. Efficacy of these injections was assessed in all groups, even though other treatment modalities like orbital debridement and exenteration were considered for moderate and severe cases. Patients were followed up for a period of 8 weeks.

Results:

Out of 82 eyes, symptomatic improvement was seen in a major proportion (72%) of patients. A statistically significant improvement in scores was noted in group A (93% improved) with a P value of 0.002, while 68.4% showed improvement in group B (P?value? 0.0001). Group C with severe disease showed minimal improvement in post?injection scores of 41% (P?value 0.086), necessitating surgical intervention. No serious adverse effect of the drug or procedure was noted.

Conclusion:

Significant improvement in scores of groups A and B highlights TRAMB as an effective and safe treatment modality in mild to moderate ROCM. It is an effective adjunct in severe cases, along with other interventions. Also, the scoring system helps in assessing the severity and guiding in management strategies.

Texto completo: DisponíveL Índice: IMSEAR (Sudeste Asiático) Revista: Indian J Ophthalmol Ano de publicação: 2022 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: IMSEAR (Sudeste Asiático) Revista: Indian J Ophthalmol Ano de publicação: 2022 Tipo de documento: Artigo